Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Boston Scientific Corp. (BSX) has a market cap of $94.85B with year-over-year revenue growth of +19.9%. Net margin stands at 14.4%. The stock trades at a P/E ratio of 32.8.
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, BSX posted revenue growth of +19.9% and trades at a P/E of 32.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.